Article: Short- and Potential Long-term Adverse Health Outcomes of COVID-19: A Rapid Review

TitleShort- and Potential Long-term Adverse Health Outcomes of COVID-19: A Rapid Review
Authors
KeywordsCOVID-19
SARS-CoV-2
coronavirus infection
health outcomes
complications
Issue Date2020
PublisherTaylor & Francis Group, on behalf of Shanghai ShangyixunCultural Communication Co., Ltd. The Journal's web site is located at https://www.tandfonline.com/toc/temi20/current
Citation
Emerging Microbes & Infections, 2020, v. 9 n. 1, p. 2190-2199 How to Cite?
AbstractThe coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living. Long-term adverse outcomes have been reported with similar diseases from other coronaviruses, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Emerging evidence suggests that COVID-19 adversely affects different systems in the human body. This review summarizes the current evidence on the short-term adverse health outcomes and assesses the risk of potential long-term adverse outcomes of COVID-19. Major adverse outcomes were found to affect different body systems: immune system (including but not limited to Guillain-Barré syndrome and paediatric inflammatory multisystem syndrome), respiratory system (lung fibrosis and pulmonary thromboembolism), cardiovascular system (cardiomyopathy and coagulopathy), neurological system (sensory dysfunction and stroke), as well as cutaneous and gastrointestinal manifestations, impaired hepatic and renal function. Mental health in patients with COVID-19 was also found to be adversely affected. The burden of caring for COVID-19 survivors is likely to be huge. Therefore, it is important for policy makers to develop comprehensive strategies in providing resources and capacity in the healthcare system. Future epidemiological studies are needed to further investigate the long-term impact on COVID-19 survivors.
Persistent Identifierhttp://hdl.handle.net/10722/288378
ISSN
2018 Impact Factor: 6.212
2015 SCImago Journal Rankings: 1.774
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLeung, TYM-
dc.contributor.authorChan, AYL-
dc.contributor.authorChan, EW-
dc.contributor.authorCHAN, VKY-
dc.contributor.authorChui, CSL-
dc.contributor.authorCowling, BJ-
dc.contributor.authorGAO, L-
dc.contributor.authorGE, MQ-
dc.contributor.authorHung, IFN-
dc.contributor.authorIp, MSM-
dc.contributor.authorIp, P-
dc.contributor.authorLau, KK-
dc.contributor.authorLau, CS-
dc.contributor.authorLau, LKW-
dc.contributor.authorLeung, WK-
dc.contributor.authorLi, X-
dc.contributor.authorLuo, H-
dc.contributor.authorMan, KKC-
dc.contributor.authorNG, VWS-
dc.contributor.authorSiu, CW-
dc.contributor.authorWan, EYF-
dc.contributor.authorWing, YK-
dc.contributor.authorWong, CSM-
dc.contributor.authorWong, KHT-
dc.contributor.authorWong, ICK-
dc.date.accessioned2020-10-05T12:11:59Z-
dc.date.available2020-10-05T12:11:59Z-
dc.date.issued2020-
dc.identifier.citationEmerging Microbes & Infections, 2020, v. 9 n. 1, p. 2190-2199-
dc.identifier.issn2222-1751-
dc.identifier.urihttp://hdl.handle.net/10722/288378-
dc.description.abstractThe coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living. Long-term adverse outcomes have been reported with similar diseases from other coronaviruses, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Emerging evidence suggests that COVID-19 adversely affects different systems in the human body. This review summarizes the current evidence on the short-term adverse health outcomes and assesses the risk of potential long-term adverse outcomes of COVID-19. Major adverse outcomes were found to affect different body systems: immune system (including but not limited to Guillain-Barré syndrome and paediatric inflammatory multisystem syndrome), respiratory system (lung fibrosis and pulmonary thromboembolism), cardiovascular system (cardiomyopathy and coagulopathy), neurological system (sensory dysfunction and stroke), as well as cutaneous and gastrointestinal manifestations, impaired hepatic and renal function. Mental health in patients with COVID-19 was also found to be adversely affected. The burden of caring for COVID-19 survivors is likely to be huge. Therefore, it is important for policy makers to develop comprehensive strategies in providing resources and capacity in the healthcare system. Future epidemiological studies are needed to further investigate the long-term impact on COVID-19 survivors.-
dc.languageeng-
dc.publisherTaylor & Francis Group, on behalf of Shanghai ShangyixunCultural Communication Co., Ltd. The Journal's web site is located at https://www.tandfonline.com/toc/temi20/current-
dc.relation.ispartofEmerging Microbes & Infections-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCOVID-19-
dc.subjectSARS-CoV-2-
dc.subjectcoronavirus infection-
dc.subjecthealth outcomes-
dc.subjectcomplications-
dc.titleShort- and Potential Long-term Adverse Health Outcomes of COVID-19: A Rapid Review-
dc.typeArticle-
dc.identifier.emailLeung, TYM: mleungty@hku.hk-
dc.identifier.emailChan, AYL: adrc@hku.hk-
dc.identifier.emailChan, EW: ewchan@hku.hk-
dc.identifier.emailChui, CSL: cslchui@hku.hk-
dc.identifier.emailCowling, BJ: bcowling@hku.hk-
dc.identifier.emailHung, IFN: ivanhung@hkucc.hku.hk-
dc.identifier.emailIp, MSM: msmip@hku.hk-
dc.identifier.emailIp, P: patricip@hku.hk-
dc.identifier.emailLau, KK: gkklau@hku.hk-
dc.identifier.emailLau, CS: cslau@hku.hk-
dc.identifier.emailLau, LKW: llkw127@hku.hk-
dc.identifier.emailLeung, WK: waikleung@hku.hk-
dc.identifier.emailLi, X: sxueli@hku.hk-
dc.identifier.emailLuo, H: haoluo@hku.hk-
dc.identifier.emailSiu, CW: cwdsiu@hkucc.hku.hk-
dc.identifier.emailWan, EYF: yfwan@hku.hk-
dc.identifier.emailWong, KHT: khtw@hku.hk-
dc.identifier.emailWong, ICK: wongick@hku.hk-
dc.identifier.authorityChan, EW=rp01587-
dc.identifier.authorityChui, CSL=rp02527-
dc.identifier.authorityCowling, BJ=rp01326-
dc.identifier.authorityHung, IFN=rp00508-
dc.identifier.authorityIp, MSM=rp00347-
dc.identifier.authorityIp, P=rp01337-
dc.identifier.authorityLau, KK=rp01499-
dc.identifier.authorityLau, CS=rp01348-
dc.identifier.authorityLeung, WK=rp01479-
dc.identifier.authorityLi, X=rp02531-
dc.identifier.authorityLuo, H=rp02317-
dc.identifier.authoritySiu, CW=rp00534-
dc.identifier.authorityWan, EYF=rp02518-
dc.identifier.authorityWong, ICK=rp01480-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1080/22221751.2020.1825914-
dc.identifier.pmid32940572-
dc.identifier.pmcidPMC7586446-
dc.identifier.scopuseid_2-s2.0-85092274256-
dc.identifier.hkuros315376-
dc.identifier.volume9-
dc.identifier.issue1-
dc.identifier.spage2190-
dc.identifier.epage2199-
dc.identifier.isiWOS:000581492300001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl2222-1751-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats